The Stanford v Roche case before the US Supreme Court addresses complex questions of patent ownership under the Bayh-Dole Act. This dispute underscores the ongoing challenges universities face in managing intellectual property developed with federal funding.
Read more about War Over Patent Ownership – Stanford v. RocheTag: Patent Litigation
Patent Damages: How Much is Too Much?
The Uniloc v Microsoft case has reignited the debate on calculating patent damages, with the US Federal Circuit rejecting the 25 percent rule as a basis for reasonable royalty. This decision is likely to shape future patent infringement litigation both in the US and globally.
Read more about Patent Damages: How Much is Too Much?Open Source – A Business Reality
Open source has become integral to modern business, expanding beyond software into diverse sectors. This post examines the legal challenges, including patent disputes, that companies face with open source adoption. Managing these risks is essential to maximise the benefits of open source.
Read more about Open Source – A Business RealityStory of an Unchallenged Patent: Certainly Uncertain
This post analyses the uncertainty inherent in interpreting patent claim scope under Indian, US, and European regimes. Despite formal clarity requirements, the true boundaries of protection remain subject to individual interpretation and litigation outcome.
Read more about Story of an Unchallenged Patent: Certainly UncertainPharmaceutical Business Strategy – A Brand Name Perspective
The post explores how brand name drug companies exploit regulatory provisions to maintain market dominance during generic drug challenges. It details the legal and procedural mechanisms involved, focusing on the strategic use of the 30 month stay period under the Hatch Waxman Act.
Read more about Pharmaceutical Business Strategy – A Brand Name PerspectivePharmaceutical Business Strategy – A Generics Perspective
This article examines the strategy of generic drug companies in challenging pharmaceutical patents, focusing on Paragraph IV certifications and related litigation. It highlights trends, success rates, and the increasing participation of Indian companies in the US generics market.
Read more about Pharmaceutical Business Strategy – A Generics PerspectiveAssessing Patent Risks in India
This post examines the essential steps for assessing patent risks in India, focusing on infringement analysis and the tests for equivalence. It also considers the relevance of exemptions and the need for detailed, technology-specific evaluation in patent matters.
Read more about Assessing Patent Risks in IndiaTemporary Injunction Cases
This post examines two landmark Indian cases where courts declined temporary injunctions in patent infringement suits. The judgments clarify the principles guiding interim relief, including the need for a prima facie case and a favourable balance of convenience.
Read more about Temporary Injunction CasesTemporary Injunction: J. Mitra Vs. Kesar Medicaments
In J. Mitra Vs. Kesar Medicaments, the Court examined criteria for granting a temporary injunction in a patent infringement suit. The analysis considered patent validity, infringement, and the balance of convenience, ultimately favouring interim relief for the patent holder.
Read more about Temporary Injunction: J. Mitra Vs. Kesar MedicamentsIndian Patent Revocation: K. Manivannan, Vs. Shri M. Mani, Proprietor Valasumani Lathe Works
The Appellate Board dismissed the revocation request against Valasumani Lathe Works’ patent, finding no anticipation from prior art or abandoned applications. This decision clarifies key principles on anticipation and prior art for Indian patent law.
Read more about Indian Patent Revocation: K. Manivannan, Vs. Shri M. Mani, Proprietor Valasumani Lathe Works